small nuclear ribonucleoprotein polypeptide G pseudogene 5Genealiases: []
Q-omics provides the consensus-scored SNRPGP5 profile across patient tissues and cancer cell-line models. SNRPGP5 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, SNRPGP5 is differentially expressed in 9, with the highest sampling consensus in HNSC. Additionally, SNRPGP5 RNA expression shows 8,867 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight KIRP, HNSC, and UVM as cancer lineages where SNRPGP5 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SNRPGP5 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes SNRPGP5 survival associations across molecular data types. SNRPGP5 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SNRPGP5 RNA expression–survival associations across cancer types. High SNRPGP5 expression shows unfavorable associations in UVM and ACC, but favorable associations in KIRP, PAAD, SKCM and CESC. The KIRP Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .002). Together, the overview and detailed table identify KIRP as the clearest survival context for SNRPGP5 RNA expression.
This table summarizes SNRPGP5 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 9. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for SNRPGP5. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. SNRPGP5 shows lower tumor expression in KICH and PAAD and higher tumor expression in HNSC, LIHC, UCEC and LUAD. The HNSC box plot shows higher SNRPGP5 RNA expression in tumor versus normal tissue (log2 FC = +0.251, t-test p < 0.001).
This table shows molecular features associated with SNRPGP5 in patient tissues and cancer cell lines. In patient samples, SNRPGP5 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
